Quality of life in women with breast cancer undergoing chemotherapy: a comparative cross-sectional study of CICC ports and PICC-ports [0.03%]
Marco Soldani,Daniele Privitera,Chiara Caradonna et al.
Marco Soldani et al.
Early outcomes of accelerated partial breast irradiation and dosimetric comparison of volumetric modulated arc therapy and three-dimensional conformal radiotherapy [0.03%]
Tomomi Aoshika,Nobue Uchida,Fumihiro Tomita et al.
Tomomi Aoshika et al.
S Kusuhara,T Kogawa,M Shimokawa et al.
S Kusuhara et al.
Time-dependent diffusion MRI for non-invasive differentiation of benign and malignant breast lesions and evaluation of proliferation index biomarkers [0.03%]
时间依赖性扩散磁共振乳腺癌影像诊断及增殖指数生物标志物评估
Luqing Ru,Yanlin Tang,Jigeng Zhang et al.
Luqing Ru et al.
Impact of sentinel lymph node biopsy versus axillary lymph node dissection on shoulder range of motion in early rehabilitation after breast cancer surgery [0.03%]
前哨淋巴结活检与腋窝淋巴结清扫术后早期康复期肩关节活动度的比较研究
Honami Hieda,Yasunori Umemoto,Aoi Aasaumi et al.
Honami Hieda et al.
UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer [0.03%]
HER2阳性乳腺癌病理完全缓解的预测型生物标志物UGT2B17
Ana Gil-Torralvo,M Ángeles Domínguez-Cejudo,Sonia Molina-Pinelo et al.
Ana Gil-Torralvo et al.
Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM) [0.03%]
淋巴管肌瘤病(LAM)患者乳腺癌全乳放疗3例报告
Rumiko Kinoshita,Mitsuchika Hosoda,Fumi Kato et al.
Rumiko Kinoshita et al.
Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival [0.03%]
异体フリー誘導多能干细胞衍生的间充质干细胞/基质细胞促进自体脂肪移植存活的功效研究
Hideharu Nakamura,Takaya Makiguchi,Takahiro Yamaguchi et al.
Hideharu Nakamura et al.
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer [0.03%]
外周髓源性抑制细胞在晚期乳腺癌中的预后意义
Haruka Kanaoka,Masayuki Nagahashi,Junko Tsuchida et al.
Haruka Kanaoka et al.
PIK3CA mutation in ER-negative and HER2-positive breast cancer with apocrine differentiation [0.03%]
ER阴性HER2阳性具有顶小体分化乳腺癌中PIK3CA突变分析
Fumi Nozaki,Yoko Nakanishi,Yukari Hirotani et al.
Fumi Nozaki et al.
Background: Targeted therapies for PIK3CA-mutated breast cancer are currently limited to the hormone receptor (HR)-positive and HER2-negative subtype. Carcinoma with apocrine differentiation (apocrine ca.) is typically ch...